1
Clinical Trials associated with Allogenic Adipose Tissue Derived-MSCs(China Medical University Hospital)Allogenic Adipose Tissue Derived-MSCs Therapy in Patients With Connective Tissue Diseases-associated Interstitial Lung Disease(CTD-ILD): Phase I/IIa Clinical Trial
Connective tissue disease (CTD), an autoimmune and inflammatory disease, usually accompanied by lung interstitial/alveolar inflammation and fibrosis (so called interstitial lung disease, ILD). The prevalence and mortality rate of CTD-ILD increase in recent several years. Although the use of corticosteroids and strong immunosuppressants can improve ILD in some patients with CTD, progressive lung fibrosis which needs lung transplantation and results in respiratory failure, even with mortality is observed. Currently, stem cell therapy is a breakthrough in the treatment of CTD-ILD, and the effective therapy with stem cells for patients with ILD have been reported.
100 Clinical Results associated with Allogenic Adipose Tissue Derived-MSCs(China Medical University Hospital)
100 Translational Medicine associated with Allogenic Adipose Tissue Derived-MSCs(China Medical University Hospital)
100 Patents (Medical) associated with Allogenic Adipose Tissue Derived-MSCs(China Medical University Hospital)
100 Deals associated with Allogenic Adipose Tissue Derived-MSCs(China Medical University Hospital)